 aztreonam cefotaxim treatment gram-neg spontan periton cirrhot patient aztreonam cefotaxim cirrhot patient episod gram-neg spontan periton patient therapeut group similar characterist group episod gm aztreonam hr group episod gm cefotaxim hr plan period peak trough serum ascit fluid level antibiot sever time minimum inhibitori concentr caus microorgan eleven patient first hr therapi aztreonam group cefotaxim group patient sign symptom infect ascit fluid cultur neg hr case patient aztreonam group clinic failur patient aztreonam group cefotaxim group treatment overal mortal rate patient aztreonam group cefotaxim group NS hepatoren syndrom digest tract hemorrhag frequent caus death occur first hr treatment streptococc superinfect patient aztreonam group antibiot low dose studi effect infect use aztreonam initi empir treatment concomit antibiot gram-posit infect possibl streptococc superinfect cefotaxim advantag therapeut altern patient popul